Double-Donor transplant offers hope for leukemia patients lacking matches
NCT ID NCT06904482
Summary
This study is testing a new transplant method for adults with high-risk leukemia or myelodysplastic syndromes (MDS) who do not have a perfectly matched donor. It combines cells from a partially matched family donor with cells from umbilical cord blood. The goal is to see if this two-donor approach can safely control the cancer and help patients live longer without the disease returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Conditions
Explore the condition pages connected to this study.